DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Semprex-D (Acrivastine / Pseudoephedrine Hydrochloride) - News

 
 



News related to Semprex-D (Acrivastine / Pseudoephedrine) and/or conditions it is approved for

Allergic Rhinitis: 3 Years of Immunotherapy Needed
Source: Medscape Allergy & Clinical Immunology Headlines [2017.02.14]
When treatment was shortened from 3 years to 2, sublingual immunotherapy proved no better than placebo for patients with grass pollen allergy.
Medscape Medical News

Hay Fever (Allergic Rhinitis)
Source: MedicineNet Allergic Cascade Specialty [2016.10.07]
Title: Hay Fever (Allergic Rhinitis)
Category: Diseases and Conditions
Created: 12/31/1997 12:00:00 AM
Last Editorial Review: 10/7/2016 12:00:00 AM

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015